Systemic upregulation of neutrophil α-defensins and serine proteases in neutrophilic asthma

Background The well-characterised airway inflammatory phenotypes of asthma include eosinophilic, neutrophilic, mixed eosinophilic/neutrophilic and paucigranulocytic asthma, identified based on the proportion of sputum granulocytes. Systemic inflammation is now recognised as an important part of some airway diseases, but the involvement of systemic inflammation in the pathogenesis of airway inflammatory phenotypes of asthma remains unknown. Methods Induced sputum samples and peripheral blood were collected from participants with asthma (n=36). Airway inflammatory cell counts were performed from induced sputum and inflammatory phenotype assigned based on the airway eosinophil and neutrophil cut-offs of 3% and 61%, respectively. RNA was extracted from whole blood and gene expression profiles were generated (Illumina Humanref-8 V3) and analysed using GeneSpring GX11. Results There were six genes classified as differentially expressed between the four asthma phenotypes, including the α-defensins (DEFA) 1, 1B, 3 and 4 and neutrophil proteases cathepsin G (CTSG) and elastase (ELA2). Systemic expression of DEFA1,1B,3,4,CTSG and ELA2 was significantly higher in the neutrophilic asthma (NA) phenotype. Microarray results of the α-defensins and neutrophil proteases were successfully validated using real-time PCR. Plasma elastase was significantly increased in people with neutrophilic airway inflammation. Conclusion There is systemic upregulation of α-defensin and neutrophil protease expression in NA, which may represent proinflammatory effects on the bone marrow and the release of immature neutrophils into the circulation. This demonstrates a systemic inflammatory component in NA that further differentiates this from other asthma phenotypes and indicates different mechanisms in NA.

[1]  R. Stockley,et al.  Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence , 2010, Thorax.

[2]  K. Hartshorn,et al.  Review: Defensins and cathelicidins in lung immunity , 2010, Innate immunity.

[3]  J. Cowan,et al.  Effects of steroid therapy on inflammatory cell subtypes in asthma , 2009, Thorax.

[4]  P. McElduff,et al.  Assessment and Reproducibility of Non-Eosinophilic Asthma Using Induced Sputum , 2009, Respiration.

[5]  R. Scott,et al.  Differential gene expression and cytokine production from neutrophils in asthma phenotypes , 2009, European Respiratory Journal.

[6]  V. Siroux,et al.  Heterogeneity of asthma according to blood inflammatory patterns , 2009, Thorax.

[7]  K. Yanagihara,et al.  Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin. , 2008, The Journal of antimicrobial chemotherapy.

[8]  Mike Thomas,et al.  Cluster analysis and clinical asthma phenotypes. , 2008, American journal of respiratory and critical care medicine.

[9]  A. Soruri,et al.  Chemoattraction of Macrophages, T Lymphocytes, and Mast Cells Is Evolutionarily Conserved within the Human α-Defensin Family1 , 2007, The Journal of Immunology.

[10]  I. Pavord,et al.  Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma , 2007, Thorax.

[11]  J. Douwes,et al.  Innate immune activation in neutrophilic asthma and bronchiectasis , 2007, Thorax.

[12]  Christine T. N. Pham,et al.  Neutrophil serine proteases: specific regulators of inflammation , 2006, Nature Reviews Immunology.

[13]  E. Abraham,et al.  Peripheral Blood Neutrophil Activation Patterns Are Associated with Pulmonary Inflammatory Responses to Lipopolysaccharide in Humans1 , 2006, The Journal of Immunology.

[14]  R. Scott,et al.  Inflammatory subtypes in asthma: Assessment and identification using induced sputum , 2006, Respirology.

[15]  R. Scott,et al.  Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. , 2005, American journal of respiratory and critical care medicine.

[16]  Edward J Hollox,et al.  Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. , 2005, Human molecular genetics.

[17]  I. Olafsson,et al.  C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study , 2005, Thorax.

[18]  M. Nakazato,et al.  Differential effects of α- and β-defensin on cytokine production by cultured human bronchial epithelial cells , 2005 .

[19]  M. Nakazato,et al.  High concentrations of α-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome , 2004 .

[20]  Farshid N. Rouhani,et al.  Role of human neutrophil peptides in lung inflammation associated with alpha1-antitrypsin deficiency. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[21]  T. Ganz Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[22]  N. McElvaney,et al.  Neutrophil elastase up‐regulates interleukin‐8 via toll‐like receptor 4 , 2003, FEBS letters.

[23]  N. Chavannes,et al.  Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. , 2002, American journal of respiratory and critical care medicine.

[24]  Arthur S Slutsky,et al.  Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[25]  O. Chertov,et al.  Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells , 2000, Journal of leukocyte biology.

[26]  J. Nadel Role of neutrophil elastase in hypersecretion during COPD exacerbations, and proposed therapies. , 2000, Chest.

[27]  J. Hogg,et al.  Flow cytometric analysis of defensins in blood and marrow neutrophils , 2000, European journal of haematology.

[28]  J. Cowland,et al.  The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules , 1999, Journal of leukocyte biology.

[29]  C. Agustí,et al.  Goblet cell degranulation after antigen challenge in sensitized guinea pigs. Role of neutrophils. , 1998, American journal of respiratory and critical care medicine.

[30]  T. Ganz,et al.  Purification and characterization of defensins from cystic fibrosis sputum , 1997, Inflammation Research.

[31]  J. Hogg,et al.  Neutrophil activation and lung injury associated with chronic endotoxemia in rabbits. , 1996, Experimental lung research.

[32]  J. Hogg,et al.  Polymorphonuclear leukocyte (PMN) migration in streptococcal pneumonia: comparison of older PMN with those recently released from the marrow. , 1996, American journal of respiratory cell and molecular biology.

[33]  T. Ganz,et al.  Defensins: a family of antimicrobial and cytotoxic peptides. , 1994, Toxicology.

[34]  Jodie L Simpson,et al.  Transcriptional phenotypes of asthma defined by gene expression profiling of induced sputum samples. , 2011, The Journal of allergy and clinical immunology.

[35]  E. Wouters,et al.  Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? , 2009, Proceedings of the American Thoracic Society.

[36]  M. Nakazato,et al.  Differential effects of alpha- and beta-defensin on cytokine production by cultured human bronchial epithelial cells. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[37]  M. Nakazato,et al.  High concentrations of alpha-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. , 2004, Life sciences.